Author

Prof Morihito Okada

Institution: Hiroshima University Hospital

Observed institution: Hiroshima University Hospital

OpenAlex ID: A5113909879

Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

2020 · Tatsuro Fukuhara, Haruhiro Saito, et al. · EBioMedicine · 30

Works count: 1

Citation count: 30

H-index: 1

I10-index: 1